Bycell Structure Dispersion

JP2026102851APending Publication Date: 2026-06-23KOSE HOLDINGS CORP

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
KOSE HOLDINGS CORP
Filing Date
2026-03-23
Publication Date
2026-06-23

AI Technical Summary

Benefits of technology

【0007】 本発明の皮膚外用組成物は、リポソームとバイセル構造体の共存安定性に優れるため、皮膚に適用した際の浸透感と塗布後の膜感が良好であり、連用後のハリ感に優れるものである。そのため、本発明の皮膚外用組成物は、エモリエント効果の高いスキンケア化粧料、アンチエイジング化粧料等として有用なものである。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026102851000001
    Figure 2026102851000001
  • Figure 2026102851000002
    Figure 2026102851000002
Patent Text Reader

Abstract

Because both the liposome and bicell structure particles remain stable over the long term, this provides a highly emollient topical skin composition that combines barrier function and a penetrating feel. [Solution] A topical skin composition containing liposomes and a bicell structure, wherein the liposomes contain component (A) phospholipids, component (B) phytosterols, and component (C) polyhydric alcohols with an IOB value of 2.0 to 5.0, and the bicell structure contains at least one surfactant selected from the group consisting of component (D) phospholipids, component (E) ceramides, component (F) polyoxyethylene sterol ethers, polyoxyethylene stanol ethers, and polyglycerin fatty acid esters which are esters of polyglycerin with an average addition mole number of 5 to 20 and fatty acids having 10 to 22 carbon atoms, and component (G) a dihydric alcohol such as propylene glycol.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A topical skin composition containing liposomes and a bicell structure, The liposome is a liposome containing component (A) phospholipid, component (B) phytosterol, and component (C) polyhydric alcohol with an IOB value of 2.0 to 5.

0. The bicell structure contains at least one surfactant selected from the group consisting of component (D) phospholipids, component (E) ceramides, component (F) polyoxyethylene sterol ethers, polyoxyethylene stanol ethers, and polyglycerin fatty acid esters which are esters of polyglycerin with an average addition number of 5 to 20 and fatty acids having 10 to 22 carbon atoms, and component (G) at least one dihydric alcohol selected from the group consisting of propylene glycol, dipropylene glycol, and 1,3-butylene glycol, wherein the mass ratio of component (D) to component (F) (D) / (F) is 0.2 to 1.6, and the mass ratio of component (E) to the sum of component (D) and component (F) (E) / {(D)+(F)} is 0.1 to 0.

8. Furthermore, the topical skin composition is such that the total amount of components (A) and (B) in the liposome and the total amount of components (D) to (F) of the bicell structure are in a mass ratio of 200:1 to 1:

1.

2. The topical skin composition according to claim 1, further comprising component (H) an anionic polymer.

3. The topical skin composition according to claim 1 or 2, wherein the component (H) contains one or more selected from carboxyvinyl polymers and / or alkyl-modified carboxyvinyl polymers.